cardiology
Medicines

Why age shouldn’t be a barrier to anticoagulation

Sponsored by Bayer Australia Pty Ltd

The biggest challenge in preventing stroke in older patients with non-valvular atrial fibrillation (NVAF) still remains that many who would benefit from anticoagulation are not receiving it say experts who argue that age alone should not be the only criterion guiding the decision of whether to offer the blood thinning medication to the elderly. “Data ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic